- Home
- HALO vs ACHC Comparison
HALO vs ACHC Comparison
Compare HALO & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HALO
- ACHC
- Stock Information
- Founded
- HALO 1998
- ACHC 2005
- Country
- HALO United States
- ACHC United States
- Employees
- HALO N/A
- ACHC N/A
- Industry
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- ACHC Medical Specialities
- Sector
- HALO Health Care
- ACHC Health Care
- Exchange
- HALO Nasdaq
- ACHC Nasdaq
- Market Cap
- HALO 7.6B
- ACHC 1.7B
- IPO Year
- HALO N/A
- ACHC N/A
- Fundamental
- Price
- HALO $66.73
- ACHC $24.75
- Analyst Decision
- HALO Buy
- ACHC Strong Buy
- Analyst Count
- HALO 11
- ACHC 12
- Target Price
- HALO $73.09
- ACHC $35.33
- AVG Volume (30 Days)
- HALO 2.4M
- ACHC 3.5M
- Earning Date
- HALO 10-30-2025
- ACHC 10-31-2025
- Dividend Yield
- HALO N/A
- ACHC N/A
- EPS Growth
- HALO 68.93
- ACHC N/A
- EPS
- HALO 4.37
- ACHC 1.52
- Revenue
- HALO $1,178,672,000.00
- ACHC $3,229,609,000.00
- Revenue This Year
- HALO $32.57
- ACHC $7.23
- Revenue Next Year
- HALO $23.77
- ACHC $6.95
- P/E Ratio
- HALO $15.21
- ACHC $16.18
- Revenue Growth
- HALO 34.97
- ACHC 5.64
- 52 Week Low
- HALO $42.01
- ACHC $17.13
- 52 Week High
- HALO $79.50
- ACHC $60.52
- Technical
- Relative Strength Index (RSI)
- HALO 40.85
- ACHC 53.11
- Support Level
- HALO $63.80
- ACHC $23.50
- Resistance Level
- HALO $68.00
- ACHC $25.21
- Average True Range (ATR)
- HALO 2.26
- ACHC 1.13
- MACD
- HALO -0.67
- ACHC -0.19
- Stochastic Oscillator
- HALO 24.08
- ACHC 34.01
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
About ACHC Acadia Healthcare Company Inc.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.